Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 26;19(11):3343.
doi: 10.3390/ijms19113343.

Drosophila Models of Sporadic Parkinson's Disease

Affiliations
Review

Drosophila Models of Sporadic Parkinson's Disease

Emi Nagoshi. Int J Mol Sci. .

Abstract

Parkinson's disease (PD) is the most common cause of movement disorders and is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. It is increasingly recognized as a complex group of disorders presenting widely heterogeneous symptoms and pathology. With the exception of the rare monogenic forms, the majority of PD cases result from an interaction between multiple genetic and environmental risk factors. The search for these risk factors and the development of preclinical animal models are in progress, aiming to provide mechanistic insights into the pathogenesis of PD. This review summarizes the studies that capitalize on modeling sporadic (i.e., nonfamilial) PD using Drosophila melanogaster and discusses their methodologies, new findings, and future perspectives.

Keywords: Drosophila; animal model; sporadic Parkinson’s disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The dopaminergic (DA) neurons in the adult fly brain. Schematics of the seven major clusters of DA neurons located in the anterior and posterior brain [24,25,36]. The protocerebral anterior lateral (PAL) and protocerebral anterior medial (PAM) clusters reside in the anterior brain. Major posterior clusters include the protocerebral posterior medial 1, 2, and 3 (PPM1, PPM2, and PPM3, respectively) and the protocerebral posterior lateral clusters 1 and 2 (PPL1 and PPL2, respectively).

Similar articles

Cited by

References

    1. Kalia L.V., Lang A.E. Parkinson’s disease. Lancet. 2015;386:896–912. doi: 10.1016/S0140-6736(14)61393-3. - DOI - PubMed
    1. Poewe W. Non-motor symptoms in Parkinson’s disease. Eur. J. Neurol. 2008;15(Suppl. 1):14–20. doi: 10.1111/j.1468-1331.2008.02056.x. - DOI - PubMed
    1. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. doi: 10.1038/42166. - DOI - PubMed
    1. Kalia L.V., Lang A.E., Hazrati L.N., Fujioka S., Wszolek Z.K., Dickson D.W., Ross O.A., Van Deerlin V.M., Trojanowski J.Q., Hurtig H.I., et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72:100–105. doi: 10.1001/jamaneurol.2014.2704. - DOI - PMC - PubMed
    1. Poulopoulos M., Levy O.A., Alcalay R.N. The neuropathology of genetic Parkinson’s disease. Mov. Disord. 2012;27:831–842. doi: 10.1002/mds.24962. - DOI - PMC - PubMed

MeSH terms